Acquisitions for Aptiv and Eurofins, partnering for Spaulding and fundraising at Clinipace

By Gareth Macdonald

- Last updated on GMT

Related tags: Clinical trial, Contract research organization presents a roundup of deals in the contract research space with acquisitions by Aptiv and Eurofins, another partnership for Spaulding and fundraising by Clinipace.

US contract research organisation (CRO) Aptiv Solutions​ has bought SRA Global Clinical Development, a division of North Carolina-based SRA International.

The deal, financial terms of which were not disclosed, will see SRA’s 100-strong clinical trial and regulatory services team and offices in the US, France and the UK join the Aptiv network.

Aptiv Solutions’ CEO, Pat Donnelly, said: “With this acquisition we continue to broaden our client base and add significant expertise and scale to Aptiv Solutions​.”

Aptiv was formed earlier this year when six CROs - Averion International, Trio Clinical Research, ClinResearch, Niphix, Addplan and Fulcrum Pharma – joined to establish a CRO specialised in adaptive trial protocols.

French CRO Eurofins​ is also in acquisition mode. The firm signed a definitive, mutually-binding agreement on September 30 to acquire a 67 per cent stake in each of two Fondation Institut Pasteur de Lille subsidiaries, namely IPL Invest and IPL Santé Environnement Durable Nord.

The two IPL units specialise in environmental testing and generate around €45m a year in combined revenue. The deal, which is expected to complete later this month, follows just a few weeks after Eurofins expanded its food testing lab in Nantes and is a further example of its diversification efforts.

Spaulding Clinical Research​, which recently partnered​ with Eurofins, has entered into an accord with telemonitoring group GrandCare Systems in a deal focused on Spaulding’s iQ electrocardiograph.

The agreement, finical terms of where were not provided, will see GrandCare incorporate iQ into its in home monitoring infrastructure to create, according to the firms, a telemedicine home diagnostic service.

The partnership is the third Spaulding has signed in as many months behind its deals with Eurofins and more recently, Frontage​.

Finally for this round-up we look at US CRO Clinipace Worldwide​. The firm has raised $15m in a series C financing round led by Morgan Stanley Expansion Capital.

Clinipace said it plans to use the money to build “therapeutic expertise” and “global capacity,” but did not go into specifics.

Previously Clinipace has expanded its global footprint and offering through acquisitions – buying PFC Pharma Focus to enter the European market in May​ and regulatory affairs firm Regulus Pharmaceutical Consulting in March​.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

Related suppliers

Follow us


View more